**Core Concept**
The question is testing the knowledge of hepatotoxicity associated with inhalational anesthetics. Inhalational agents can cause liver damage through various mechanisms, including direct cytotoxic effects, oxidative stress, and mitochondrial dysfunction.

**Why the Correct Answer is Right**
Halothane is a potent inhalational agent known for its hepatotoxic potential. It is metabolized by cytochrome P450 enzymes in the liver, producing a toxic metabolite that can cause liver damage and even hepatitis. This is particularly concerning in patients with pre-existing liver disease or those who have undergone repeated exposures to halothane.

**Why Each Wrong Option is Incorrect**
**Option A:** Isoflurane is actually considered to have a low risk of hepatotoxicity compared to other inhalational agents.
**Option B:** Sevoflurane is metabolized by cytochrome P450 enzymes, but its hepatotoxic potential is considered to be lower than halothane.
**Option C:** Desflurane is also metabolized, but its metabolism is primarily by ester hydrolysis, and it is not associated with significant hepatotoxicity.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that halothane is contraindicated in patients with liver disease or those who have undergone repeated exposures to this agent. A thorough medical history and pre-anesthetic evaluation are crucial to identifying potential risks.

**Correct Answer:** C. Desflurane.